Introduction
============

Extracorporeal membrane oxygenation is life support for reversible heart and/or lung failure refractory to standard treatment, and it is used as bridge-to-recovery, bridge-to-bridge, bridge-to-transplant, or bridge-to-decision ([@B45]). This technique was developed by the CPB technology, and it is based on a partial/full bypass of the native cardiac and/or pulmonary function. Neonatal respiratory ECMO was introduced by Robert Bartlett during the 1970s for severe hypoxemic respiratory failure secondary to MAS, PPH and RDS ([@B22]). Despite the progress in neonatal care following the introduction of new therapies and ventilatory strategies, ECMO remains life-saving support for about 600--800 neonates each year worldwide ([@B305]). Across the world, from 1989 to 2017, about 27.238 newborns needed an ECMO procedure for respiratory failure, 7.592 for cardiac problems, 1.694 for extracorporeal cardiopulmonary resuscitation; the overall survival rate is 83, 64, and 66%, respectively (ELSO). Although the overall survival is high, there are consistent differences in the incidence rates between the diseases. Since 1979 the survival of ECMO patients with congenital diaphragmatic hernia and sepsis is stable at around 51 and 48%, respectively. In contrast, PPH, RDS, and MAS have a significantly higher survival of 73, 76, and 92%, each. Furthermore, cardiomyopathy and myocarditis have better survival (65 and 50%, respectively), compared to congenital heart disease and cardiogenic shock (44 and 47%, respectively) (ELSO). Nevertheless, the mortality of infants and children with congenital heart disease has reduced in recent decades as a result of the improvement of CPB techniques and myocardial protective strategies ([@B128]; [@B67]; [@B113]). Nowadays, although the clinical management of ECMO patients has remarkably progressed over the years, the rate of complications (hemostatic disorders, brain damage, AKI, sepsis) still have a high impact on patients' outcome (ELSO).

Oxidative stress plays a critical role in the genesis of tissue damage during an ECMO procedure, and newborns are particularly prone to the toxic effects of free radicals, due to the immaturity of their antioxidant systems resulting in lowered detoxification capacity ([@B77]; [@B57]; [@B274]; [@B222]; [@B284]; [@B5], [@B4]; [@B11]; [@B14]; [@B224]; [@B13]; [@B219]; [@B212]; [@B227]; [@B247]). The inflammatory response following the introduction of ECC generates a high amount of ROS contemporarily reducing endogenous antioxidants ([@B105]; [@B136]; [@B169]). Various studies associated the exposure to extracorporeal circuits (CPB, ECMO, and CRRT) with the increased oxidative stress that may negatively impact on morbidity and mortality ([@B214]). Redox imbalance is mainly induced in the early stage of ECMO, especially after the CPB, while with prolonged exposure (beyond 24 h) the TAC gradually restores ([@B320]; [@B18]; [@B98]; [@B74]; [@B192]; [@B179]; [@B66]; [@B346],[@B347]; [@B122]; [@B250]). The modulation of oxidative stress would seem to be of great clinical importance. Indeed, its manipulation through the use of exogenous antioxidants, cardioplegia during CPB, blood priming strategies, or miniaturization of the extracorporeal circuit could mitigate the ROS production ([@B122]). However, data are scant, especially for neonatal ECMO, and are mainly related to pre-clinical evidence. This review focuses on the mechanisms of oxidative stress during neonatal ECMO, involved in the pathophysiology of both short and long-term disorders as MOF, hemostatic derangements up to neurodegenerative, cardiovascular and cancer disease in adults. Lastly, a brief overview of currently available antioxidant strategies is provided ([@B147]).

Redox Biology and Oxidative Stress
==================================

Energy is produced by mitochondrial metabolism through glucose, amino acids and lipids combustion in the presence of O~2~ ([@B280]; [@B314]). Approximately 98% of O~2~ is reduced to H~2~O by the conventional combustion process, while only 2% of remaining O~2~ loses its electrons with the rear O~2~^-^ and ROS production ([@B203]; [@B314]).

The "old definition" of oxidative stress was referred to conditions in which the balance between ROS production and endogenous antioxidants break down resulting in tissue and cellular injury through lipid peroxidation, protein oxidation, and DNA damage ([@B277]). Currently, the "new definition" is much more complex, referring to an imbalance between oxidants and antioxidants in favor of the oxidants, that cause an arrest of redox signaling and/or molecular damage ([@B283]). More recently the term "reductive stress" has been introduced, but its exact definition is still unclear ([@B145]). It would seem to be due to high levels of reduced GSH and NADPH, unbalancing the redox system to the opposite oxidative extreme, which has shown to play an essential role in the pathogenesis of dilated cardiomyopathy in cases of lamin-associated muscular dystrophy ([@B208]; [@B100]; [@B292]; [@B26]).

The O~2~^-^, H~2~O~2~, OH^●^, and ONO~2~^-^ are the most common ROS, produced by aerobic metabolism ([@B277]). The intracellular O~2~^-^ arises from the one-electron reduction of molecular O~2~ that is primarily produced by the oxidation of NADPH by NOX enzymes or by electron loss from aerobic respiration in mitochondria ([@B187]; [@B39]; [@B272]). Superoxide anion is rapidly converted by SOD into H~2~O~2~, and its storage is prevented by SODs, which are mainly located in the cytosol and mitochondria. Conversely, the increase in H~2~O~2~ triggers autophagy and cell death (Figure [1](#F1){ref-type="fig"}; [@B121]; [@B64]).

![Redox Biology and Oxidative stress. The production of O~2~^-^ mainly occurs with the oxidation of NADPH into NADP+ in the presence of O~2~ and NOX, and partly from an electron's loss during the combustion of carbohydrates, amino acids, and lipids for the production of energy in mitochondria. Superoxide dismutases (SOD) immediately transforms $O_{2}^{-}$ into H~2~O~2~ which is converted in OH^●^ in the presence of iron, if not degraded by antioxidant enzymes in H~2~O. Furthermore, the excess of $O_{2}^{-}$ reacting with NO produces ON$O_{2}^{-}$, which in turn participates in oxidative damage with OH^●^. Contrarily, the standard production of O~2~^-^ contributes to the homeostasis of the redox signal. CAT, catalase; Cys--S^-^, cysteine thiolate anion; Cys-SO~2~H, cysteine sulfinic acid; Cys-SO~3~H, cysteine sulfonic acid; Cys--SOH, cysteine sulfenic acid; Fe^2+^, ferrous ions; Fe^3+^, ferric ions; GPx, glutathione peroxidases; Grx, glutaredoxin; H~2~O~2~, hydrogen peroxide; NADP+, nicotinamide adenine dinucleotide phosphate oxidated form; NADPH, nicotinamide adenine dinucleotide phosphate reduced form; NO, Nitric oxide; NOS, nitric oxide synthase; NOX, NADPH oxidase; O~2~, oxygen; O~2~^-^, superoxide anion; OH, hydroxyl radicals; ONO~2~^-^, peroxynitrite; PRx, peroxiredoxins; SOD, superoxide dismutases; Trx, thioredoxin.](fphys-09-01739-g001){#F1}

Cysteine residues within proteins are oxidized by H~2~O~2~ to sulfenic form (Cys--SOH) and reduced to its basic thiolate anion (Cys--S^-^) form by the disulfide reductases Trx and Grx ([@B334]). The excess of H~2~O~2~ further oxidizes thiolate anions to sulfinic (Cys-SO~2~H) or sulfonic (Cys-SO~3~H) classes. The sulfinic and sulfonic oxidation is irreversible and could lead to permanent protein damage that is prevented by PRx, GPx and CAT (Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}; [@B334]; [@B116]). In contrast, the OH produced by Fenton reaction in the presence of Fe^2+^ has a detrimental effect on lipids, proteins, and DNA (Figure [1](#F1){ref-type="fig"}; [@B102]).

![Thioredoxin and Peroxiredoxin system. Reduced Trx-SH catalyzes the reduction of disulfide (s--s) bridges within oxidized cell proteins. This process causes the oxidation of Trx-SH to Trx-disulfide which is subsequently reduced by TR at the expense of NADPH. The TR in its catalytic Trx reduction process uses Se as a cofactor. Reduced PRx-SH promotes the separation of two H~2~O molecules from H~2~O~2~ through a "two-step mechanism." The peroxidic cysteine sulfhydryl group of a Prx subunit is oxidized to sulfenic acid (--SOH). Subsequently, sulfenic acid condenses with the reduced cysteine group present in the other subunit to form a disulfide bond between the units. This two-step process releases two H~2~O molecules from H~2~O~2~ with the oxidation of PRx-SH to PRx-SOH to PRx-disulfide. The oxidized PRx is in turn reduced by the Trx-SH. H~2~O~2~, hydrogen peroxide; NADP+, nicotinamide adenine dinucleotide phosphate oxidated form; NADPH, nicotinamide adenine dinucleotide phosphate reduced form; PRx, peroxiredoxin; TR, thioredoxin reductase; Trx, thioredoxin.](fphys-09-01739-g002){#F2}

Nitric oxide is one of the most important and ubiquitous intracellular messengers that mediates several basic physiological processes including neurotransmission, vasodilatation, angiogenesis and host cell defense ([@B201]; [@B108]; [@B35]; [@B251]; [@B180]). NO is synthesized from L-arginine by several forms of NOS, and its reaction with O~2~^-^ produces ONO~2~^-^ which alters mitochondrial function and causes apoptosis (Figure [1](#F1){ref-type="fig"}; [@B295]; [@B241]; [@B259]).

Lipid Peroxidation
------------------

Lipid peroxidation, caused by increased ROS and RNS, is linked to many acute and chronic diseases of adulthood such as MOF, hemorrhagic and septic shock, ARDS, acute lung injury, cardiovascular pathology requiring surgery, aging, atherosclerosis, Parkinson, Alzheimer, diabetes mellitus, cataracts and rheumatoid arthritis, and several diseases of the neonatal period ([@B300]; [@B148]; [@B28]; [@B262]; [@B257]; [@B54]; [@B186]; [@B228]; [@B77]; [@B258]; [@B118]; [@B189]; [@B232]; [@B274]; [@B161]; [@B284]; [@B132]; [@B42]; [@B127]; [@B171]; [@B264]; [@B21]; [@B202]; [@B212]; [@B227]; [@B236]; [@B247]; [@B265]).

Lipid peroxidation is the oxidative decay of Puffs, which involves the abstraction of hydrogen from a carbon molecule with O~2~ insertion and consequent production of lipid peroxyl radicals and hydroperoxides ([@B302]; [@B345]; [@B7]). Hydroperoxides are very unstable and easily decompose into MDAs and 4-hydroxy-2-nonenal, while peroxidation of arachidonic acid produces isoprostanes ([@B226]; [@B185]; [@B7]). The response of the cell membrane to lipid peroxidation depends on the degree of peroxidation achieved. If lipid peroxidation rate is low, the damage is repaired by anti-oxidant defense systems. On the other hand, if the lipid peroxidation rate is high, the tissue self-repairing capacity is lost, and apoptosis or programmed cell death is induced ([@B61]; [@B17]).

Oxidative Protein Damage
------------------------

Protein oxidation damage does affect not only the cell membranes but also the enzyme system because it is exclusively constituted by proteins ([@B136]). The amino acid fragmentation, the following generation of cross-links between proteins and the oxidation of the body of the protein molecule with loss of specific (contractile, enzymatic, and transport) function is caused by ROS and RNS ([@B87],[@B88]; [@B132]). Protein Carbonyl groups (aldehydes and ketones) are produced generally by the direct oxidation of proline, arginine, lysine, and threonine residues, or by oxidative cleavage of the protein backbone, and indirectly by lipid peroxidation or reaction of reducing sugars or their oxidation products ([@B87], [@B86]). The damaged proteins, in turn, contribute to many disorders and diseases ([@B87]). Oxidized or aldehyde-modified proteins would be perceived as "foreign proteins" by the immune system, with the production of self-antibodies in rheumatoid arthritis, lupus, and scleroderma in adults ([@B205]; [@B101]; [@B261]; [@B87]; [@B147]). Moreover, always in adults, the increase of oxidized proteins has been associated with multiple diseases, like cancer, heart failure, pre-eclampsia, ARDS, Parkinson, Alzheimer, and sepsis ([@B119]; [@B191]; [@B333]; [@B49]; [@B349]; [@B1]; [@B56]). In the neonatal period, the oxidation of proteins plays a key role in some diseases such as intraventricular hemorrhage, retinopathy of prematurity, bronchopulmonary dysplasia, NEC ([@B133]; [@B260]; [@B249], [@B248], [@B246], [@B247]; [@B80]).

Oxidative DNA Damage
--------------------

Oxidative DNA damage is generated by high OH^●^ concentrations ([@B78]). ROS can damage both purines and pyrimidines in DNA and in the free cell nucleotide pool and generates 8-hydroxy-2′-deoxyguanosine that can be used as a biomarker of the injury ([@B296]; [@B24]; [@B193]). Despite the damage, the cell continues the replication process, replicating the damage and inducing the new cells to apoptosis ([@B267]). Furthermore, oxidative DNA damage would be associated with other diseases such as sepsis, carcinogenesis, neurodegenerative diseases, cardiovascular diseases, and aging ([@B78]; [@B232]; [@B132]; [@B147]; [@B19]; [@B145]; [@B175]).

Oxidative Stress and ECMO
=========================

To date, evidence of oxidative stress during ECMO are limited and are mainly related to pre-clinical studies ([@B225]; [@B309]). [@B225] observed a reduction of the antioxidant capacity of SOD and GPx on a lamb ECMO model, while increased lipid peroxidation was demonstrated on a rabbit model of ECMO ([@B309]). One study on pediatric patients described two different oxidative stress patterns during ECC; in non-survivors, lipid peroxidation augmented during the first 96 h of ECMO whereas it reached a plateau after 24 h in the survivor's group ([@B155]).

No data are currently available on critically ill neonates undergoing respiratory ECMO. Despite this gap of knowledge, previous evidence, mainly derived from studies on CPB and critically ill patients, suggested that oxidative stress is a relevant contributor to morbidity and mortality ([@B225]; [@B309]; [@B43], [@B44]; [@B136]; [@B192]). ECMO shares with both CPB and critical illness common potential triggers for increased ROS generation and redox unbalance: exposure to the extracorporeal circuit and related SIRS, transfusion burden, hyperoxia, CRRT, hemolysis, and sequestration of antioxidants into the ECMO circuit ([@B214]). We describe hereafter the possible role of these triggers in the pathogenesis of oxidative stress-related morbidity during ECC.

ECMO and Inflammation
---------------------

A SIRS-like syndrome is typically observed from the first hours after starting an ECMO procedure, as a consequence of the blood exposure to the exogenous surface of the extracorporeal device ([@B94]). Despite the use of biocompatible equipment, the interaction between biological fluids and the circuit activates both the coagulation cascade and the host inflammatory response ([@B304]; [@B244]; [@B330]; [@B306]). The humoral and cell-mediated immune response triggers the release of pro-inflammatory cytokines (IL-1β, TNFα, and IFNβ), leading to endothelial damage, disrupted microcirculation and multi-organ dysfunction, in case of suboptimal compensatory anti-inflammatory response ([@B156]; [@B155]; [@B97]; [@B253]; [@B120]; [@B3]; [@B142]; [@B134]; [@B220]; [@B2]; [@B217]; [@B151]; [@B281]; [@B271]; [@B322]). The redox biology regulates the homeostasis of innate and adaptive immune response through ROS production. Many concurrent factors (hyperoxia, blood products, sepsis, mechanical ventilation) contribute to the increased ROS generation, thus promoting an overwhelming release of pro-inflammatory cytokines (IL-1β, TNFα, and IFNβ) and eventually the SIRS-like ([@B330]; [@B83]; [@B62]; [@B163]; [@B47]; [@B329]; [@B223]).

Furthermore, the intrinsic and extrinsic coagulation cascade could be directly activated by the contact of blood with the circuit surface or lesion of endothelium, or indirectly by ROS mediation ([@B93]; [@B138], [@B139]; [@B154]; [@B200]; [@B234]; [@B114]). The intrinsic coagulative pathway would be activated exclusively during the respiratory ECMO with low thrombin generation; while the release of high amount of TF and air-blood interface would stimulate both the intrinsic and extrinsic way with high thrombin generation during the CPB ([@B192]; [@B234]; [@B181]). Indeed, TF binds to Factor VII, converting it into Factor VIIa and activating the common coagulation cascade ([@B93]; [@B192]; [@B200]; [@B234]). The intrinsic pathway is activated through the conversion of Factor XII into Factor XIIa within 10 min from the beginning of the extracorporeal procedure and is associated with an increase in Bradykinin, Kallikrein, and activation of Factor IX ([@B328]; [@B221]). Bradykinin stimulates NO, TNFα, and IL-10 production, while Kallikrein directly activates neutrophils ([@B263]; [@B317]). Factor IXa induces the activation of Factor X which in turn causes the conversion of prothrombin into thrombin and fibrinogen in fibrin resulting in thrombus formation ([@B221]). Thrombin stimulates the endothelial production of P-selectin, E-selectin, and platelet activating factor, thus increasing the adherence and activation of neutrophils and the expression of proinflammatory cytokines ([@B256]; [@B348]; [@B168]; [@B192]). Additionally, thrombin stimulates the production of ROS in endothelial and smooth muscle cells, by stimulating NOX and by up-regulating the expression of NOX sub-unit p22phox in a kinase-dependent manner ([@B140]; [@B103]).

Oxidative stress induces platelets activation and aggregation which, in turn, increases ROS production. Neutrophils participate in the amplification of the immune response; although multifocal, the activation of neutrophils occurs mainly in the oxygenator; their margination in the artificial lung, observed both in animal models and in newborns, contribute to the deterioration of the artificial membrane during ECMO ([@B253]; [@B120]; [@B178]; [@B44]; [@B217]; [@B271]).

In conclusion, the mechanism of ECMO-induced oxidative stress is a multifactorial process, in which the interaction between the immune response, the coagulation cascade, and endothelial cells amplifies ROS generation (Figure [3](#F3){ref-type="fig"}).

![Main determinants of ECMO-induced oxidative stress. Graphical representation of the interaction between the coagulation cascade, the immune response, and the endothelium in the multifactorial amplification process of the ECMO-related redox unbalance. ICAM, intercellular adhesion molecule. VCAM, vascular cell adhesion molecule.](fphys-09-01739-g003){#F3}

ECMO and Blood Transfusion
--------------------------

Blood products have been associated with increased morbidity and mortality in critically ill patients ([@B176]; [@B321]; [@B126]). Transfusion-related oxidative stress increases with the volume, and the number of PRBC transfused ([@B282]; [@B285]; [@B90]; [@B75]). [@B268] observed that blood transfusions were associated with a significant increase in oxidative stress and a reduction of IL-6 concentration in critically ill adults. The transfusion of aged PRBC was associated with an increase of oxidative stress, as a consequence of the reduced Se content in older PRBC. Se is an essential trace element, which is incorporated into selenoproteins, some of which have antioxidants function (i.e., GPx) ([@B215]). In premature newborns, RBC transfusions were associated with an increase of MDA, a lipid peroxidation product, both in the bronchoalveolar lavage fluid and in urine ([@B323]). This data suggested that RBC transfusion could increase pulmonary oxidative damage and worse prognosis ([@B76]).

Extracorporeal membrane oxygenation, as well as CPB or exchange transfusion, are procedures that expose patients to a significant increase in PRBC transfusions and therefore to oxidative stress ([@B213]; [@B199]; [@B48]; [@B10]). Newborns receive an average of 60 ml/kg/day of PRBC during an ECMO procedure ([@B293]). This high blood requirement depends on (1) priming of the ECMO circuit with blood, to avoid acute hemodilution, (2) frequent blood samples for coagulation tests, (3) hemolysis-related anemia due to centrifugal pumps and, occasionally, (4) spontaneous bleeding from cannulation sites and surgical wounds. According to the ELSO registry, these latter events represents about 19% of all hemorrhagic complications during neonatal respiratory ECMO, impacting on survival (ELSO). Overall, the mortality rate is increased among neonates exposed to large volumes of PRBC transfusions ([@B288]; [@B117]; [@B126]). Dos Santos et al. observed a 27.8% mortality in critically ill infants exposed to transfusions during the hospital stay, with an increased relative risk of death of 1.49 in those infants who received at least one transfusion compared to controls ([@B104]). In a cohort of extremely low birth weight infants, the incidence of mortality was 24% in patients transfused compared to 8.5% in the control group ([@B126]). Similarly, Smith and co-authors observed a 24% increase in the odds of hospital death associated with every 10 ml/kg/day of PRBC transfusion in patients during respiratory ECMO ([@B288]).

In addition to PRBC, newborns on ECMO require approximately 25 ml/kg/day of PCs ([@B293]). Platelet count is reduced by 40--50% during ECMO, partly due to the activation of the coagulation cascade ([@B230]). Moreover, PCs are a source of ROS, especially $O_{2}^{-}$, which modulate platelet activation and aggregation ([@B182]; [@B25]). The increase in ROS, whose impact on the patient's oxidation state is still unknown, is mainly related to the storage process ([@B289]).

ECMO and Hemolysis
------------------

ECMO-related hemolysis is a common phenomenon among pediatric patients and represents an independent predictor of mortality ([@B235]; [@B89]). It consists of the RBCs lysis with following release of hemoglobin into the plasma ([@B269]). The shear stress is the main causative mechanism for hemolysis during mechanical support, and some risk factors have been identified, such as the negative inlet pressure, pump speed, pump and oxygenator type, cavitation and priming solution ([@B291]; [@B197]; [@B269]). In addition, oxidative stress is a determinant of hemolysis ([@B38]; [@B318]). Lipid peroxidation and protein damage of cell membranes from ROS cause enzymatic inactivation, depolarization of the cell membrane and a change in its permeability, resulting in cell lysis ([@B211]; [@B174]). The mechanical and oxidative stress during ECMO leads to the release of the PFHb, which is cleared by hemoglobin scavengers ([@B89]). However, in case of severe hemolysis, the hemoglobin-scavenging mechanisms become saturated, resulting in hemoglobinemia and hemoglobinuria ([@B269]). The PFHb may exert either a direct toxic effect (i.e., renal damage) or may cause endothelial dysfunction, by binding NO. The NO consumption leads to increased systemic and pulmonary resistance, platelet activation and aggregation, endothelial adhesion, fibrin deposition and thrombin formation ([@B269]).

Moreover, the shear stress induces procoagulant conformational changes of the pVWF, which interacts with circulating platelets enhancing their adhesion and aggregation properties ([@B84]).

Furthermore, high levels of PFHb inhibit the cleavage of pVWF by ADAMTS-13, contributing to increased clotting within the mechanical devices ([@B85]). Eventually, hyperbilirubinemia and iron release constitute additional drivers of the hemolysis-induced morbidity and mortality ([@B95]; [@B167]). Besides hemolysis, the mechanical stress may hesitate into sublethal RBCs damage, leading to increased fragility and decreased deformability of RBCs ([@B166]). Their consequent failure to enter small capillaries causes end-organ dysfunction, through the impairment of tissue oxygenation and microcirculation ([@B326]). Based on the concepts mentioned above, ECMO providers should monitor the hemolysis, as it is strictly associated with increased mortality and morbidity (kidney injury, vascular impairment, need for PRBC and PCs transfusion, thrombosis).

Moreover, efforts should focus on the technological progress, because of specific components of the circuit act as main drivers of the ECMO-induced hemolysis, such as the oxygenator ([@B331]). The use of smaller pediatric oxygenators was associated with greater shear stress and, hence, increased hemolysis, when compared to larger adult oxygenators ([@B331]). Although the relative contribution of each circuit component on the hemolysis and related oxidative stress is unknown, the use of a centrifugal pump and small size connectors should be considered as potential sites of increased hemolysis ([@B197]; [@B331]). Furthermore, the use of red-to-infrared radiation (R/NIR) to stabilize erythrocyte membranes with increased resistance to oxidative stress seems promising ([@B162]; [@B177]; [@B68]; [@B319], [@B318]).

Technology advances should target the development of new, more bio-compatible, circuit-blood interfaces in order to reduce hemolysis and oxidative stress.

ECMO and Hyperoxia
------------------

The antioxidant capacity of tissues is overtaken with O~2~^-^ production during hyperoxia. Oxygen toxicity in the perinatal period is well established, and many efforts have been made to define safety targets during neonatal resuscitation and care ([@B307]; [@B16]; [@B115]; [@B15]; [@B276]; [@B315]; [@B278]; [@B275]; [@B204]).

Nevertheless, hyperoxia remains a significant driver for radical O~2~ species generation, especially during ECC ([@B55]). Hyperoxia is frequent during cardiac surgery in CPB and seems to play a key role in the development of oxidative stress as a consequence of post-ischemic reperfusion ([@B59]; [@B37]). The clamp of the aorta induces heart and lung ischemia while declamping generates reperfusion, and either action produces an inflammatory response. On-pump cardiac surgery is associated with increased oxidative stress if compared to off-pump surgery ([@B210]; [@B58]). The post-ischemic reperfusion, rather than hyperoxia *per se*, seems to play a role; there is evidence from pediatric cardiac surgery that isolated hyperoxia does not increase oxidative stress and inflammation if compared with normoxia ([@B160]; [@B51], [@B52]). Although ECMO does not directly cause ischemia/reperfusion, patients requiring ECMO experience prolonged periods of pre-ECMO hypoxia causing an increase in oxidative stress ([@B82]; [@B150]; [@B66]). ROS generation following hyperoxia is significantly exaggerated when hyperoxia is subsequent a period of hypoxia, due to the dysfunction of the post-ischemic mitochondrial electron transport chain ([@B231]). [@B299] identified hyperoxia within 48 h of ECMO following cardiac surgery as an independent risk factor for mortality at 30 days post-operatively, while [@B309] observed how VV-ECMO more than VA-ECMO would increase pulmonary lipid peroxidation following endotoxemia-induced hypoxia. Lipid peroxidation of the lung is a known consequence of sepsis and inflammation, but it has also been described as a consequence of tissue reperfusion ([@B96]; [@B159]; [@B71]; [@B70]). In the study by [@B309] hyperoxic reperfusion of the hypoxic lung following VV-ECMO, caused a significant increase of plasma MDA as an index of lipid peroxidation, higher than that observed in VA-ECMO where the hyperoxic blood supply to the lung is less.

More recently, similar results have been observed by [@B55] that showed higher in-hospital mortality among hyperoxic patients submitted to ECMO compared to normoxics, ascribing the high mortality to the effects of ROS on poor cardiac output rather than the SIRS-like syndrome, hemostatic activation and MOF.

ECMO and Continuous Renal Replacement Therapies
-----------------------------------------------

Oxidative stress is a common condition in kidney diseases ([@B335]; [@B149]); it is induced by renal pathology itself, reduced antioxidant intake associated with malnutrition, CRRT with the loss of antioxidant molecules during filtration and the contact of blood with CRRT circuit ([@B336]; [@B149]; [@B50]; [@B290]; [@B313]; [@B194]; [@B79]; [@B239]). The SIRS-like syndrome, which typically occurs in the early hours of ECMO, is associated with hypotension, oligo-anuria, decreased lung compliance, pulmonary edema, increased plasma concentrations of pro-inflammatory cytokines and neutrophils' activation ([@B156]; [@B94]). AKI and FO complicate neonatal ECMO runs in more than half of cases, with a negative impact on survival rates ([@B153]; [@B327]; [@B298]; [@B123]; [@B350]). Therefore, hemofiltration and hemodialysis have become a standard of care in the management of AKI during ECMO ([@B153]; [@B218]; [@B243]; [@B65]). During CRRT, inflammation is activated by an increase of ROS and inflammatory cytokines (TNFα, IL-1, and IL-6) ([@B303]; [@B36]) and a reduction of antioxidant proteins as hydrosoluble vitamin C and uric acids ([@B152]; [@B343]; [@B194]). The use of biocompatible filtration systems by using vitamin E-coated filters reduces the oxidative stress linked to the contact of blood with exogenous materials ([@B344]). [@B279] suggested an early filtration treatment to anticipate FO, and reduce mortality rate. As reported by ELSO registry, about 33% of neonatal respiratory ECMO and 38% of cardiac ECMO require renal replacement therapy (ELSO). As a result of the combination of two ECC systems, the hemolysis-related oxidative stress would increase ([@B65]). The in-line use of CRRT would limit the ECMO-related inflammation by reducing the concentrations of TNFα, IL-1β, IL-6, and IL-8 ([@B164]).

ECMO Post-cardiopulmonary Bypass
--------------------------------

Adult patients with cardiovascular diseases and neonatal patients with congenital cyanotic heart diseases have an increased level of oxidative stress, even before heart surgery, if compared to the healthy population ([@B112]; [@B132]; [@B169]; [@B287]).

Moreover, cardiac surgery is always associated with both systemic inflammation and a variable degree of oxidative stress, which might contribute to post-operative complications, failure of single and multiple organs and mortality ([@B173]; [@B30]; [@B12]; [@B252]; [@B338]). [@B252] observed that the increase of asymmetric dimethylarginine and 8-iso-prostaglandin F~2α~ was associated with an unfavorable outcome of patients undergoing coronary artery bypass grafting. Similarly, [@B12] has shown how the increase of O~2~^-^ and ONO~2~^-^ concentration was closely related to atrial fibrillation, need for inotropic drugs and lengthening of hospital stay during post-cardiac surgery.

The main cause of oxidative stress during cardiac surgery is the exposure to the foreign surface of the extracorporeal circuit, hypothermia, and circulatory arrest associated with systemic inflammation, ischemia-reperfusion injury, altered hemostatic status ([@B255]; [@B107]; [@B74]; [@B192]; [@B311]; [@B125]; [@B169]). Approximately 3--5% of patients undergoing congenital cardiac surgery require post-CPB extracorporeal support, due to the weaning failure following myocardial dysfunction, low cardiac output state, cardiac or respiratory arrest, pulmonary hypertension, or shunt occlusion ([@B6]; [@B273]; [@B209]). The long duration of ECMO post-CPB might impair the organ function, thus predisposing to an increased risk of complications (i.e., sepsis) and mortality ([@B106]; [@B60]; [@B273]; [@B184]; [@B266]; [@B110]).

Clinical Relevance of Oxidative Stress During Neonatal ECMO
===========================================================

The role of continuing oxidative stress has been established in the long term, in a variety of chronic diseases, such as diabetes mellitus, atherosclerosis and neurodegenerative illness ([@B146]). Currently, the interest is moving toward the effects of the redox unbalance in the acute illness ([@B20]). Here, we summarize the available evidence in relation to the role of the oxidative stress in critical conditions, which often occur during ECMO (Figure [4](#F4){ref-type="fig"}).

![Clinical relevance of ECMO-induced oxidative stress. AF, atrial fibrillation; ARDS, acute respiratory distress syndrome; ECC, extracorporeal circuit; IBD, intestinal bowel disease; MOF, multi-organ failure; SIRS, systemic inflammatory response syndrome.](fphys-09-01739-g004){#F4}

Sepsis and Multi-Organ Failure
------------------------------

A wealth of studies has shown that the normal redox balance is altered in septic shock and multiple organ failure, due to both an increase in $O_{2}^{-}$ derived free radicals and a decrease in the plasma antioxidant potential ([@B233]; [@B135]). Adult septic patients have higher plasma CAT and SOD if compared to healthy controls ([@B325]). Moreover, non-survivors of sepsis have shown higher levels of SOD and a reduced plasmatic antioxidant status, which was associated with unfavorable outcomes ([@B81]; [@B143]). The sepsis-related MOF, which remains the major cause of death in intensive care units, is associated with oxidative stress and mitochondrial dysfunction ([@B40]; [@B124]). Two antioxidants targeting the protection of mitochondria (MitoQ and MitoVitE) through the reduction of oxidative stress have been beneficial in a rat model of acute sepsis ([@B198]). Other potential oxidative-induced mechanisms for MOF development have been proposed, as a result of the anti-oxidant impairment secondary to GSH and Se depletion, suggesting a positive effect of Se supplementation ([@B40]; [@B206]; [@B46]).

Hemostatic Derangement and Anticoagulation Management
-----------------------------------------------------

Maintaining the hemostatic homeostasis during ECMO is extremely challenging and, despite technical advances, bleeding and thrombosis remain serious complications ([@B229]). The hemostatic perturbation during ECMO is a multifactorial process, and the redox imbalance is one of the main contributing factors. Besides the dilutional coagulopathy, which depends on priming compositions and affects both clotting factors and platelets, the shear stress has a key role as it induces platelet dysfunction, fibrinolysis activation, acquired von Willebrand syndrome and intravascular hemolysis ([@B140]; [@B138], [@B139]; [@B114]). As previously mentioned, the oxidative stress is strictly associated with the shear stress, resulting in endothelial activation (see section "ECMO and Inflammation") and enhanced hemolysis (see section "ECMO and Hemolysis") ([@B140]; [@B138], [@B139]; [@B154]; [@B103]; [@B221]).

Moreover, the exposure to the exogenous circuits triggers a SIRS-like syndrome, which is associated with the ROS generation, the release of pro-inflammatory cytokines, the activation of the intrinsic coagulation pathway with a potential procoagulant effect ([@B221]). The clot formation triggers the consumption of coagulation factors and platelets, thus increasing the risk of disseminated intravascular coagulopathy and bleeding ([@B221]). The anticoagulation management should be modulated, by taking into account the drivers of hemostatic unbalance mentioned above.

Biomarkers of the Redox State
-----------------------------

Based on the relevant clinical implication of the redox unbalance during ECMO, the identification of diagnostic markers would help in the detection, monitoring, and follow-up of the redox potential in ECMO neonates. However, the profile of biomarkers of both oxidative stress and antioxidant defenses during neonatal ECMO has not been characterized yet. Evidence can be derived from previous pre-clinical and clinical studies, which evaluate the pro-oxidative potential during and after the exposure to an extracorporeal circuit (i.e., CRRT, CPB) ([@B301]; [@B216]). As most of the research has been performed on the adult population, the evaluation of the redox status in neonatal systemic diseases (i.e., septic shock) may provide further insights into the age-related antioxidant deficiency ([@B23]). Among potential pro-oxidant biomarkers, the d-ROMs have been evaluated in a dialyzer, while the MDA has been applied in a porcine ECMO model ([@B301]; [@B66]).

Additionally, as nitro-oxidative stress is involved in a large variety of pathological mechanisms, the biomarkers validated for the detection of nitrosation and nitration would be of interest ([@B73]). However, their application in the extra-corporeal setting is still lacking. The anti-oxidant response may be evaluated through the detection of the TAC, SOD, and GSx activity ([@B301]; [@B216]). Moreover, the reduction of key trace elements, such as Se, copper, and zinc might suggest a reduced anti-oxidant activity ([@B216]). In clinical practice, the oxidative stress may be indirectly presumed through the monitoring of inflammatory markers, such as the increased levels of IL-6 and IL-8 or by evaluating the hemolysis with the PFHb levels ([@B269]; [@B301]; [@B84]).

Strategies to Reduce Oxidative Stress: Update on Antioxidants
=============================================================

The ROS production is regulated by intra and extracellular antioxidant systems, which are impaired during the perinatal period and critical illness ([@B206]; [@B216]). ECMO further complicates the issue, by adding specific sources for redox state unbalance ([@B206]; [@B216], [@B214]; [@B164]; [@B221]; [@B31]). The antioxidant system of the newborns is immature with both a reduction of antioxidant enzymes (SOD, CAT, and GPx) and non-enzymatic antioxidants (vitamin E, β-carotene, melatonin, ceruloplasmin, transferrin, coenzyme Q) while ascorbic acid and bilirubin are present only for a short period after birth ([@B137]; [@B130]; [@B31]). Free iron levels are significantly higher than in adults, causing an increased Fenton reaction, which in turn stimulates the production of OH^●^ ([@B274]). Furthermore both the SIRS-like and the sequestration into the ECMO/hemofilter circuit reduce the level of trace elements (copper, manganese, zinc, iron, Se as cofactors for SOD, GPx, and CAT function) and non-enzymatic antioxidants (albumin, uric acid, vitamins C and E) ([@B50]; [@B341]; [@B342]; [@B27]; [@B308]; [@B157]; [@B316]; [@B206]; [@B337]; [@B72]).

Based on the paucity of data regarding patients in ECMO both neonatal and adult, we will illustrate previous data regarding the use of anti-oxidants in critically ill adult patients undergoing surgery, CRRT or CPB. Moreover, taking into account the peculiarity of the perinatal period, we will mention some data on anti-oxidant strategies studied in neonatal conditions where oxidative stress is one of the pathogenic mechanisms, such as sepsis or NEC ([@B240]; [@B254]) (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Among others, vitamin A, vitamin E, vitamin C, SOD, and NAC have been studied to reduce tissue damage mediated by oxidative stress with contrasting results ([@B310]; [@B297]; [@B324]; [@B41]; [@B92]).

Antioxidants have two main mechanisms of action: the prevention, inactivating the free radical present in the systems and the scavenging of the active radical, suppressing the chain initiation or breaking the chain propagation. They may exert their effect by many actions including electron donation, hydrogen donor, metal ion chelation, co-antioxidants, radical scavenger, peroxide decomposer, singlet oxygen quencher, enzyme inhibitor or by gene expression regulation ([@B196]).

*Selenoproteins* contribute to the function of many enzymes among which GSx, TRs, and methionine sulfoxide reductase and seem to protect the cardiovascular system against oxidative stress ([@B270]; [@B172]; [@B158]; [@B27]; [@B157]). Based on the reduction of Se levels in critically ill patients or after cardiac surgery, Se supplementation has been investigated in this contexts with contradictory results ([@B206]; [@B294]; [@B46]). To date, there are no data to support its extended use ([@B8]; [@B207]). Although not conclusive, neonatal supplementation with oral or parenteral Se in the first weeks of life to preterm infants led to a reduction in the proportion of infants having one or more episodes of sepsis ([@B91]). The administration of pre and post-operative *vitamin C* in cardiac surgical adults has led to a reduction of post-operative atrial fibrillation, which seems to be associated with increased atrial oxidative stress and ONO~2~^-^ formation ([@B53]).

Moreover, supplementation with ascorbic acid caused a reduction of plasma levels of oxidative stress during hemodialysis and restoration of endothelial function in critically ill patients ([@B109]; [@B332]).

Similarly, *vitamin E*-coated dialysis membranes used in adult patients on hemodialysis led to a decrease in reactive oxygen metabolites and derivatives, an increase of TAC and superoxide dismutase ([@B301]). In addition, a decrease in post-operative atrial fibrillation has been documented after the supplementation of pre and post-operative *NAC* in surgical adult patients ([@B238]). [@B240] have shown a beneficial effect of NAC in a murine NEC model in terms of reduced levels of oxidative stress (MDA) and inflammation (TNFα), with increased antioxidant activity of the SOD. Also concerning the supplementation of *glutamine*, data are not conclusive. Indeed, previous studies showed that infusion of glutamine during and for 3 days after cardio-surgery in adult patients led to an increase of glutamine blood levels and GSH activity without clinical improvement ([@B111]). Enteral glutamine either alone or in combination with arginine has been tested in healthy newborn rats showing a reduction of oxidative stress. These results may suggest a potential benefit of glutamine and arginine supplementation in the prevention of NEC in premature neonates with insufficient oxidative resistance ([@B183]). The evidence is building on the neonatal use of the ROS scavenger *melatonin*. Its supplementation in newborns with sepsis within the first 12 h after diagnosis has led to a reduction of lipid peroxidation products (MDA) and improvement of clinical outcomes ([@B129]). The post-operative administration of melatonin reduced the proinflammatory cytokines and NO levels in newborns undergoing surgery ([@B131]).

Moreover, a reduction of late-onset sepsis risk ratio has been shown in newborn supplemented with *lactoferrin* and a reduction of the risk of antibiotic treatment failure in septic newborns exposed to *zinc* ([@B29]; [@B245]). Additional promising agents are the *apocynin*, an NOX inhibitor applied in the animal model of stroke and brain injury induced by ischemia-riperfusion, and the *α-lipoic acid*, a GSH-mediated antioxidant used in adults undergoing surgery during ECC ([@B242]; [@B165]; [@B188]; [@B9]; [@B63]; [@B69]; [@B339]; [@B286]; [@B312]). Novel antioxidant molecules, such as the ROS scavenger *edaravone*, showed promising results. In a pre-clinical model of neonatal sepsis the administration of edaravone 30 min after the injury has led to both a biochemical and clinical improvement ([@B170]). Other agents like *hyperbaric oxygen and medical ozone* have been suggested to reduce oxidative stress by enhancing the antioxidant system. The technique based on the use of O~2~/ozone mix was previously applied in CRRT with promising results, even if its mechanism of action remains still unveiled ([@B33], [@B32]; [@B34]; [@B99]). Data on the use of ozone in ECMO are lacking and might be a future area of interest. Lastly, it is worth mentioning the potential role of hMSCs in ischemia/reperfusion-induced lung injury, by acting through anti-oxidant, anti-inflammatory, and anti-apoptotic defense pathways ([@B237]; [@B144]; [@B340]; [@B190]; [@B141]; [@B195]).

Conclusions and Future Perspectives
===================================

The imbalance of the redox system induced by the ECC is a field of active research, but many aspects of neonatal ECMO and its potential harm remain unsolved. Key points for both caregivers and researchers of the perinatal area addressing the burden of ECMO should include the following:

1.  • Improve our knowledge of the mechanisms of oxidative stress during neonatal ECMO, both in pre-clinical and clinical settings, with a focus on the biochemical and cellular mechanism that could contribute to multi-organ damage.

2.  • Define biomarkers for oxidative stress that could be a potential target for pharmacological approaches.

3.  • Support technological research to improve ECMO circuit miniaturization and biocompatibility.

4.  • Prevent the redox state unbalance during ECMO, through the promotion of rational use of blood products, the maintenance of well-defined O~2~ targets, the prevention of hemolysis and AKI, the timely resort to in-line renal replacement therapy, the simplification of ECMO circuit lines.
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AKI

:   acute kidney injury

ARDS

:   acute respiratory distress syndrome

ATP

:   adenosine triphosphate

CAT

:   catalase

CPB

:   cardiopulmonary bypass

CRRT

:   Continuous Renal Replacement Therapies

Cys--S^-^

:   cysteine thiolate anion

Cys-SO~2~H

:   cysteine sulfinic acid

Cys-SO~3~H

:   cysteine sulfonic acid

Cys--SOH

:   cysteine sulfenic acid

d-ROMs

:   reactive oxygen metabolism and derivatives

ECC

:   extracorporeal circulation

ECMO

:   extracorporeal membrane oxygenation

ELSO

:   extracorporeal life support organization

Fe^2+^

:   ferrous ions

Fe^3+^

:   ferric ions

FO

:   fluid overload

GPx

:   glutathione peroxidases

Grx

:   glutaredoxin

GSH

:   glutathione

H~2~O~2~

:   hydrogen peroxide

hMSCs

:   hypoxia-preconditioned mesenchymal stem cells

IFNβ

:   interferon β

IL

:   interleukin

MAS

:   meconium aspiration syndrome

MDA

:   malondialdehyde

MOF

:   multi-organ failure

NAC

:   N-acetylcysteine

NADP^+^

:   nicotinamide adenine dinucleotide phosphate oxidated form

NADPH

:   nicotinamide adenine dinucleotide phosphate reduced form

NEC

:   necrotizing enterocolitis

NO

:   Nitric oxide

NOS

:   nitric oxide synthase

NOX

:   NADPH oxidase

O~2~

:   oxygen

O~2~^-^

:   superoxide anion

OH

:   hydroxyl radicals

ONO~2~^-^

:   peroxynitrite

PCs

:   platelet concentrates

PFHb

:   plasma free hemoglobin

PPH

:   persistent pulmonary hypertension

PRBC

:   packed red blood cells

PRx

:   peroxiredoxins

PUFA

:   polyunsaturated fatty acid

pVWF

:   plasmatic Von Willebrand factor

RBCs

:   red blood cells

RDS

:   respiratory distress syndrome

RNS

:   reactive nitrogen species

ROS

:   reactive oxygen species

Se

:   selenium

SIRS

:   systemic inflammatory response syndrome

SOD

:   superoxide dismutases

TAC

:   total antioxidant capacity

TF

:   tissue factor

TNFα

:   tumor necrosis factor α

TR

:   thioredoxin reductase

Trx

:   thioredoxin

VA-ECMO

:   venous-arterial ECMO

VV-ECMO

:   venous-venous ECMO
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